Source: Matthew Perrone, WRAL, 12/23/21

 U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration announcement on Merck's molnupiravir comes one day after the agency cleared a competing drug from Pfizer. Pfizer's pill, Paxlovid, is likely to become the first-choice treatment against the virus, because of its superior benefits and milder side effects.

For more of this story, click here.